Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Echinococcosis laboratory findings
Introduction
Overview
Overview
In the patients suspected of echinococcosis, enzyme-linked immunosorbent assay (ELISA) and the indirect hemagglutination test are highly sensitive procedures for the initial screening of serum for cystic echinococcosis. In case of alveolar echinococcosis, serologic test results are usually positive at high titers. Comparing a patient’s titers with both purified-specific and shared antigens permits the serologic discrimination between patients infected with E. multilocularis and those infected with E. granulosus.
Laboratory Findings
Laboratory Findings
In the patients suspected of echinococcosis, enzyme-linked immunosorbent assay (ELISA) and the indirect hemagglutination test are highly sensitive procedures for the initial screening. [1]
Serologic Tests
Enzyme-linked immunosorbent assay (ELISA) and the indirect hemagglutination test are highly sensitive procedures for the initial screening of serum. Specific confirmation of reactivity can be obtained by demonstrating echinococcal antigens by immunodiffusion (arc 5) procedures or immunoblot assays (8-, 21– kD bands).
Serologic test results are usually positive at high titers. Comparing a patient’s titers with both purified-specific and shared antigens permits the serologic discrimination between patients infected with E. multilocularis and those infected with E. granulosus.
| Laboratory Tets | Findings |
|---|---|
| CBC |
|
| Antibody testing
(Immunoglobulin concentrations) |
|
| Liver function tests |
|
| Serology tests |
|
References
References
- ↑ Siracusano A, Teggi A, Ortona E (2009). “Human cystic echinococcosis: old problems and new perspectives”. Interdiscip Perspect Infect Dis. 2009: 474368. doi:10.1155/2009/474368. PMC 2771156. PMID 19888428.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mahshid Mir, M.D. [2]Â ; Cafer Zorkun, M.D., Ph.D. [3]; Kalsang Dolma, M.B.B.S.[4]; Aditya Ganti M.B.B.S. [5]